Skip to content
Logo - Pepaxti
Menu
  • Change Region

    • Global

      Global

    • Germany

      Germany

      You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de

    • Spain

      Spain

      You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es

    • Italy

      Italy

      You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Italian operations at oncopeptides.it

    Change Language

    • English
    • Svenska
  • ONCO
    1.82 SEK
    -2.9%
    -0.05 SEK
  • Company
    • Company
    • Company news
    • Culture & values
    • Our history
      • Our history
      • Founders
    • Strategy
    • Board of Directors
      • Board of Directors
      • Work of the Board of Directors
    • Leadership
    • Governance
      • Governance
      • Corporate Governance reports
      • Governance structure
      • General meeting
        • General meeting
        • Annual General Meeting 2025
        • Past general meetings
      • Nomination committee
        • Nomination committee
        • Nomination Committee 2025
        • Past nomination committees
      • Board committees
      • Remuneration
        • Remuneration
        • Remuneration reports
      • Auditors
      • Internal control
      • Articles of association
    • Sustainability
      • Sustainability
      • Environmental responsibilities
      • Social Responsibility
      • Responsible Governance
      • Policies
    • Career
      • Career
      • Career Opportunities
      • Meet our people
  • Science
    • Science
    • Science news
    • Melflufen
      • Melflufen
      • Multiple myeloma
      • Mechanism of action
    • Clinical Program
      • Clinical Program
      • Clinical Development
      • O-12-M1
      • HORIZON
      • OCEAN
      • ANCHOR
      • BRIDGE
      • PORT
      • LIGHTHOUSE
      • ASCENT
      • HARBOUR
    • Pipeline
      • Pipeline
      • PDC platform
      • SPiKE platform
      • Intellectual property
    • Investigator Initiated Trials
  • Product
    • Product
    • Pepaxti®
    • Regulatory status
    • Access Programs
  • Investors
    • Investors
    • Investor news
    • Press releases
    • Investor Relations Contact
    • The share
      • The share
      • Share price calculator
      • Ownership
      • Insiders
      • Trading
      • Share capital development
      • Analysts
      • Dividend policy
    • Financial reports
    • Oncopeptalks
    • Calendar
    • Share issues
      • Share issues
      • Rights issue May 2024
      • Share issue July 2022
      • Share issue March 2021
      • Share issue May 2020
      • Share issue June 2019
      • Share issue January 2019
      • Share issue March 2018
  • Contact
    • Contact
    • Media
      • Media
      • Press releases
      • Media contact
      • Image bank
    • Facilities
    • Medical Information
    • Whistleblowing
  • Change Region

    • Global

      Global

    • Germany

      Germany

      You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de

    • Spain

      Spain

      You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es

    • Italy

      Italy

      You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Italian operations at oncopeptides.it

    Change Language

    • English
    • Svenska
  • ONCO
    1.82 SEK
    -2.9%
    -0.05 SEK
Home / Archives for triggerfish_root
  • Company in brief
  • Company news
  • Culture and values
  • Our history
  • Science news
  • Pipeline
  • Press releases
  • Investor news
  • The share
  • Contact
  • Facilities
  • Whistleblowing
About cookies Privacy Policy Privacy Policy - Pharmacovigilance Terms of use Glossary
© 2024 Oncopeptides AB (publ). All rights reserved. Registration number Oncopeptides AB: 556596-6438. VAT number Oncopeptides AB: SE556596643801